Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Trial Profile

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Phase of Trial: Phase II

Latest Information Update: 01 Jan 2019

At a glance

  • Drugs Bendamustine (Primary) ; Bleomycin (Primary) ; Brentuximab vedotin (Primary) ; Cyclophosphamide (Primary) ; Dacarbazine (Primary) ; Doxorubicin (Primary) ; Etoposide (Primary) ; Prednisone (Primary) ; Vinblastine (Primary) ; Vincristine (Primary) ; Filgrastim; Filgrastim
  • Indications Hodgkin's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Dec 2018 Status changed from not yet recruiting to recruiting.
    • 06 Dec 2018 New trial record
    • 29 Nov 2018 Planned number of patients changed from 125 to 200.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top